Biography
As Chief Medical Officer of Pfizer, Dr. Habtezion leads Pfizers Worldwide Medical & Safety organization responsible for ensuring that patients, physicians, and regulatory agencies are provided with information on the safe and appropriate use of Pfizer medications.
She is a tenured and endowed Professor of Medicine, on a leave of absence from Stanford University who led translation research funded by multiple NIH, DOD, and foundation grants focused on understanding disease mechanisms in pancreatic and intestinal inflammatory diseases. She served as an Associate Dean for Academic Affairs in the School of Medicine, a faculty member in Stanfords Immunology Ph.D. program, Neuroscience Institute, Cancer Institute, Maternal & Child Health Research Institute, interdisciplinary biosciences institute Bio-X, and faculty fellow at Stanfords ChEM-H.
She is the American Pancreas Association President, Fellow of the American Gastroenterological Association, an Allen Distinguished Investigator, elected member of the American Society for Clinical Investigation and Association of American Physicians.
Track Co-Chairs:
Linda Giudice, UCSF
Yoel Sadovsky, UPMC
Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health: